FTC Puts Conditions on Novartis AG's Proposed Acquisition of GlaxoSmithKline's Oncology Drugs
February 23, 2015 at 11:34 AM EST
Global pharmaceutical company Novartis AG has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in ...
